Purchases and Sales Made in Q4 2022 in Chemomab Therapeutics Ltd. (CMMB)
This table provides information about the institutional ownership of Chemomab Therapeutics Ltd. (CMMB) during Q4 2022. The information is specifically focused on institutions that hold shares of Chemomab Therapeutics Ltd..
Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
---|---|---|---|---|---|---|---|
Feb 14, 2023
Q4 2022
|
Ikarian Capital, LLC
Dallas, TX |
BUY
|
- |
67.5K+ 27.45% |
$128K - $216K
|
313K
$517K
|
|
Jan 31, 2023
Q4 2022
|
Kestra Private Wealth Services, LLC
|
BUY
|
- |
31.2KNew |
$59.4K - $100K
|
31.2K
$51.5K
|
|
Feb 14, 2023
Q4 2022
|
Boothbay Fund Management, LLC
New York, NY |
BUY
|
- |
14.2K+ 38.1% |
$27.1K - $45.6K
|
51.6K
$85.2K
|
|
Feb 07, 2023
Q4 2022
|
Envestnet Asset Management Inc
|
BUY
|
- |
1.15K+ 9.77% |
$2.18K - $3.66K
|
12.9K
$21.2K
|
|
Feb 14, 2023
Q4 2022
|
Morgan Stanley
New York, NY |
BUY
|
- |
400+ 6.45% |
$760 - $1.28K
|
6.6K
$10.9K
|
|
Jan 30, 2023
Q4 2022
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
BUY
|
- |
0New |
$0 - $0
|
0
$0
|
|
Feb 08, 2023
Q4 2022
|
Ubs Group Ag
|
SELL
|
- |
-259- 5.3% |
$492 - $829
|
4.63K
$7.64K
|
|
Feb 10, 2023
Q4 2022
|
Advisor Group Holdings, Inc.
Phoenix, AZ |
SELL
|
- |
-613- 8.77% |
$1.16K - $1.96K
|
6.37K
$10.5K
|